Shandong, China

Xuemei Zhang

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 8.2

ph-index = 1


Location History:

  • Shandong, CN (2014 - 2015)
  • Yantai, CN (2019)

Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Xuemei Zhang: Innovator in Pharmaceutical Compositions

Introduction

Xuemei Zhang is a notable inventor based in Shandong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release microspheres. With a total of 3 patents, his work has advanced the effectiveness of drug delivery systems.

Latest Patents

One of Xuemei Zhang's latest patents is titled "Pharmaceutical compositions of goserelin sustained release microspheres." This invention provides a composition that includes goserelin, at least one poly (lactide-co-glycolide), and poloxamer or PEG. The sustained release microspheres developed by Zhang exhibit comparatively high bioavailability, promoting the drug's full effect and achieving an entrapment efficiency of over 90%. Another significant patent is related to "Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride." This disclosure covers the polymorphs, methods for their preparation, and their uses.

Career Highlights

Xuemei Zhang has worked with Shandong Luye Pharmaceutical Co., Ltd., where he has contributed to various innovative projects. His expertise in pharmaceutical formulations has positioned him as a key player in the industry.

Collaborations

Throughout his career, Zhang has collaborated with notable colleagues, including Youxin Li and Wanhui Liu. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical technologies.

Conclusion

Xuemei Zhang's contributions to pharmaceutical innovations, particularly in sustained release formulations, highlight his role as a leading inventor in the field. His patents reflect a commitment to improving drug delivery systems, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…